Post-eradication poliovirus facility-associated community risks

被引:13
|
作者
Dowdle, Walter R.
Wolff, Chris
机构
[1] Task Force Child Survial & Dev, Decatur, GA 30030 USA
[2] WHO, Vaccine Assessment & Monitoring, CH-1211 Geneva 27, Switzerland
关键词
poliovirus containment; community risks; transmission risks; laboratory containment;
D O I
10.1016/j.biologicals.2006.03.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Minimizing the risk of poliovirus transmission from the poliovirus facility to an increasingly susceptible community is crucial when global poliovirus transmission and OPV use stops. Community risks of exposure to wild poliovirus as well as Sabin strains are highest from facility personnel who are unknowingly contaminated or infected. Immunization with OPV or IPV prevents poliomyelitis, but neither vaccine fully inhibits silent infection of the gut. Facility environments maintained at low relative humidity (< 50%) may reduce poliovirus survival and inhalation risk. Circulating antibodies reduce personnel infection risks from injection or virus entry through breaks in skin or mucous membranes. Community exposure risk through inhalation of contaminated air effluent is likely low in most modern facilities. Community risks through ingestion of liquid effluents are facility-specific and may range from high to low. This assessment of community risks, when combined with assessments of facility-specific hazards and the consequences of wild or Sabin poliovirus transmission, provides the foundation for effective risk management. (c) 2006 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 50 条
  • [1] Smallpox in the Post-Eradication Era
    Meyer, Hermann
    Ehmann, Rosina
    Smith, Geoffrey L.
    VIRUSES-BASEL, 2020, 12 (02):
  • [2] Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication Era
    Bandyopadhyay, Ananda S.
    Singh, Harpal
    Fournier-Caruana, Jacqueline
    Modlin, John F.
    Wenger, Jay
    Partridge, Jeffrey
    Sutter, Roland W.
    Zaffran, Michel J.
    EMERGING INFECTIOUS DISEASES, 2019, 25 (07) : 1363 - 1369
  • [3] SMALLPOX AND ITS POST-ERADICATION SURVEILLANCE
    JEZEK, Z
    KHODAKEVICH, LN
    WICKETT, JF
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1987, 65 (04) : 425 - 434
  • [4] HIV therapy in the post-eradication era
    Vella, S
    Palmisano, L
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2000, 14 (01): : 34 - 37
  • [5] Post-eradication challenges in the developing world
    Ogden, EW
    CONSIDERATIONS FOR VIRAL DISEASE ERADICATION, WORKSHOP SUMMARY: LESSONS LEARNED AND FUTURE STRATEGIES, 2002, : 169 - 172
  • [6] SMALLPOX - POST-ERADICATION VIGILANCE CONTINUES
    不详
    WHO CHRONICLE, 1982, 36 (03) : 87 - 91
  • [7] Strategic priorities for addressing post-eradication outbreaks
    Kadlec, RP
    CONSIDERATIONS FOR VIRAL DISEASE ERADICATION, WORKSHOP SUMMARY: LESSONS LEARNED AND FUTURE STRATEGIES, 2002, : 157 - 163
  • [8] Monkeypox outbreak in the post-eradication era of smallpox
    Kandra, Naga Vishnu
    Varghese, Anjaly Mary
    Uppala, Praveen Kumar
    Uttaravelli, Upendrarao
    Lavanya, Butti
    Shabana, S. K. M.
    Somarouthu, Venkata Saibaba
    Balijepalli, Murali Krishna
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2023, 35 (01):
  • [9] Polio: Present status and post-eradication policies
    Tarantola, D
    VACCINES: PREVENTING DISEASE AND PROTECTING HEALTH, 2004, (596): : 23 - 30
  • [10] Monkeypox outbreak in the post-eradication era of smallpox
    Naga Vishnu Kandra
    Anjaly Mary Varghese
    Praveen Kumar Uppala
    Upendrarao Uttaravelli
    Butti Lavanya
    S. K. M. Shabana
    Venkata Saibaba Somarouthu
    Murali Krishna Balijepalli
    The Egyptian Journal of Internal Medicine, 35